Ballicules.com

Mefenamic acid

PONSTEL

Pronunciation: me-fe-NAM-ik AS-id (PON-stel)

Mefenamic acid ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Mefenamic acid ballicule
Mefenamic acid PONSTEL mascot mnemonic cartoon
Visual mnemonic: Mefenamic acid mascot
“Mef’s Pony’s tail”
“The N said... NSAID”

What it isFenamate NSAID; dysmenorrhea and mild to moderate pain.

Why this oneParticularly effective for dysmenorrhea, where it reduces menstrual blood loss as well as pain.

What limits itDiarrhea is prominent among the fenamates, and overdose causes seizures. Standard NSAID GI and renal risk; it raises serum lithium.

Mefenamic acid molecular structure (skeletal formula)
Molecular structure: Mefenamic acid

FDA-approved for

FDA label

BOXED WARNING NSAID class risk: serious cardiovascular thrombotic events (MI, stroke) — contraindicated in CABG setting; serious GI bleeding, ulceration, and perforation, which can be fatal.
FDA dosingPopulationStartTargetMax
Mild to moderate painAdults & ≥14 yr500 mg once, then 250 mg q6h PRN250 mg q6h PRN
Primary dysmenorrheaAdults & ≥14 yr500 mg once, then 250 mg q6h (from onset of bleeding)250 mg q6h

Renal Should not be given to patients with pre-existing renal disease or significantly impaired renal function; avoid in advanced renal disease unless benefits outweigh risks.

Hepatic May require reduced doses in acute or chronic hepatic disease.

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Avoid at ~30 weeks gestation and later (premature closure of fetal ductus arteriosus); limit dose/duration at 20–30 weeks (oligohydramnios/fetal renal dysfunction).

Lactation Present in human milk in low amounts; weigh benefits against potential effects on the infant.

Cost

Mefenamic acid (PONSTEL)
What pharmacies pay · NADAC 9/30/26
Strength#/mogeneric $/unitCostPlus
250 mgcapper unit$0.95/eaoffered

Generic entry2010

⚠ BOXED WARNINGS

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger3 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk3 / 4

Legacy pregnancy categoryMultiple / indication-, trimester- or formulation-dependent

Defining liabilityGI bleeding, kidney injury, hypertension and fluid retention; many agents increase lithium concentrations.

Open Mefenamic acid in the interactive console ↗

Memory aids: interaction avatars

Mefenamic acid Box: minimal PK interactions avatar mnemonic
Box: minimal PK interactions

Open Mefenamic acid in the interactive console ↗